Antitumor effects of two less-calcemic vitamin D analogs (Paricalcitol and QW-1624F2-2) in squamous cell carcinoma cells

scientific article published on January 2006

Antitumor effects of two less-calcemic vitamin D analogs (Paricalcitol and QW-1624F2-2) in squamous cell carcinoma cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1159/000098813
P698PubMed publication ID17237623

P2093author name stringGary H Posner
Candace S Johnson
Donald L Trump
Barbara A Foster
Adebusola A Alagbala
P2860cites workMitogen-activated protein (MAP) kinase pathways: regulation and physiological functionsQ29547189
Cancer cell cyclesQ29547756
The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB.Q33783562
Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancerQ34415244
Vitamin D and prostate cancer prevention and treatmentQ35569014
Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidismQ44358766
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectvitamin DQ175621
P304page(s)483-492
P577publication date2006-01-01
P1433published inOncologyQ2016300
P1476titleAntitumor effects of two less-calcemic vitamin D analogs (Paricalcitol and QW-1624F2-2) in squamous cell carcinoma cells
P478volume70

Reverse relations

cites work (P2860)
Q61023219Calcitriol and cancer therapy: A missed opportunity
Q46153079EB1089 induces Skp2-dependent p27 accumulation, leading to cell growth inhibition and cell cycle G1 phase arrest in human hepatoma cells
Q35107605Early growth inhibition is followed by increased metastatic disease with vitamin D (calcitriol) treatment in the TRAMP model of prostate cancer
Q34005247Epigenetic silencing of CYP24 in the tumor microenvironment
Q33680919Synergistic antileukemic activity of carnosic acid-rich rosemary extract and the 19-nor Gemini vitamin D analogue in a mouse model of systemic acute myeloid leukemia
Q35962274Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development
Q41587565The conformational dynamics of H2-H3n and S2-H6 in gating ligand entry into the buried binding cavity of vitamin D receptor
Q36996576Vitamin D in cutaneous carcinogenesis: part II.

Search more.